Nam K. Tran, Ph.D., HCLD (ABB), FAACC
Molecular Infectious Disease Diagnostics
- Director of Clinical Chemistry, Special Chemistry/Toxicology, and Point-of-Care Testing
- Senior Director of Clinical Pathology
- Associate Clinical Professor
Dr. Tran is a board certified clinical chemist with special interest and expertise in biomarkers of acute injury in critical care settings, and point-of-care testing including molecular infectious disease testing.
Dr. Tran's research interest includes the development and clinical implementation biomarkers of acute and rapid molecular infectious disease diagnostics including technologies used at the point of care. He also has interest and expertise in the use of artificial intelligence and machine learning applied to these same areas and how data sciences can integrate technologies and platforms into a "diagnostic ecosystem."
Ph.D., Comparative Pathology, UC Davis, Davis CA 2008
M.S., Pharmacology and Toxicology, UC Davis, Davis CA 2011
B.S., UC Davis, Davis CA 2003
High Complexity Laboratory Director (ABB) - Clinical Chemistry,
American Association of Clinical Chemistry
American Burn Association
Honors and Awards
Outstanding Research Abstract, International Critical and Point-of-Care Testing (CPOCT) Meeting, American Association for Clinical Chemistry (AACC), 2018
Resident Teaching Award, Dept. of Pathology and Laboratory Medicine, UC Davis, 2017
American Association for Clinical Chemistry Outstanding Speaker Award, 2016
UC Davis School of Medicine Dean�s Award for Excellence in Teaching, 2014
Select Recent Publications
Rashidi HH, Sen S, Palmieri TL, Blackmon T, Wajda J, Tran NK. Early recognition of burn- and trauma-related acute kidney injury: a pilot comparison of machine learning techniques. Sci Rep. 2020 Jan 14;10(1):205.
Tran NK, Sen S, Palmieri TL, Lima K, Falwell S, Wajda J, Rashidi HH. Artificial intelligence and machine learning for predicting acute kidney injury in burned patients: A proof of concept. Burns. 2019;4(6):1350-1358.
DuBois JA, Slingerland RJ, Fokkert M, Roman A, Tran NK, Clarke W, Sartori DA, Palmieri TL, Malic A, Lyon ME, Lyon AW. Bedside Glucose Monitoring-Is it Safe? A New, Regulatory-Compliant Risk Assessment Evaluation Protocol in Critically Ill Patient Care Settings. Crit Care Med. 2017 Apr;45(4):567-574.
Tran NK, Godwin ZR, Steele AN, Wolf SE, Palmieri TL. Clinical impact of accurate point-of-care glucose monitoring for tight glycemic control in severely burned children. Ped Crit Care Med. 2016 Sep;17(9):e406-412.
Howell E, Sen S, Palmieri T, Godwin Z, Bockhold J, Greenhalgh D, Tran NK*. Point-of-care B-type natriuretic peptide and neutrophil gelatinase-associated lipocalin measurements for acute resuscitation: a pilot study. J Burn Care Res. 2015 Mar-Apr;36(2):e26-33.
Sen S, Godwin ZR, Palmieri T, Greenhalgh D, Steele AN, Tran NK*. Whole blood neutrophil gelatinase-associated lipocalin predicts acute kidney injury in burn patients. J Surg Res. 2015 Mar 20.
Tran NK, Godwin ZR, Bockhold JC, Passerini AG, Cheng J, Ingemason M. Clinical impact of sample interference on intensive insulin therapy in severely burned patients: a pilot study. J Burn Care Res. 2014 Jan-Feb;35(1):72-9.
Tran NK*, Wisner DH, Albertson TE, Cohen S, Greenhalgh D, Palmieri TL, Polage C, Kost GJ. Multiplex polymerase chain reaction pathogen detection in patients with suspected septicemia after trauma, emergency, and burn surgery. Surgery. 2012 Mar;151(3):456-63.
Tran NK*, Greenhalgh DG, Palmieri TL, Kost GJ. Multiplex PCR pathogen detection in two severely burned patients with suspected septicemia. J Burn Care Res. 2011 Nov-Dec;32(6):e172-7.
Louie RF, Tang Z, Albertson TE, Cohen S, Tran NK, Kost GJ. Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia. Crit Care Med. 2008 May;36(5):1487-92.